September 8, 2008 8:00AM Eastern Daylight Time

FDA Completes Successful Audit of Azopharma’s Cyanta Analytical Laboratories Facility

HOLLYWOOD, Fla. – Azopharma Product Development Group is pleased to announce the successful FDA audit of its Cyanta Analytical Laboratories facility in Maryland Heights, MO. The audit occurred from Aug 19 - 20 and produced no 483s or other major observations.

Mr. Phil Meeks, CEO of Azopharma Product Development Group commented, “We are very pleased with the results of the recent FDA audit. It demonstrates our commitment to quality systems and personnel.”

Cyanta Analytical Laboratories is a member of the Azopharma Product Development Group and provides analytical testing to the pharmaceutical, biotechnology and medical device industries. Cyanta is an emerging leading service provider in the development of inhalation devices. The Cyanta facility was previously audited in 2006 which also produced no 483s or major observations.

Azopharma Product Development Group Includes:

• Azopharma Contract Pharmaceutical Services - Integrated product development and CTM manufacturing for all dosage forms.
• ApiCross Drug Delivery Technologies - Proprietary drug delivery platforms to solve difficult molecular challenges.
• Cyanta Analytical Laboratories - Analytical chemistry and inhalation services from development to quality control testing.
• AniClin Preclinical Services - Preclinical services in support of early product development.
• IQsynthesis - Synthetic chemistry services from discovery to clinical API supplies including large scale API synthesis.
• • AvivoClin Clinical Services - Human clinical pharmacology services for Phase I/II/III clinical trials.
• ADMEquant Bioanalytical Services - Bioanalytical research analysis of pharmaceutical compounds in all matrices.
• Acromon Clinical Research Organization- Clinical monitoring, data management and statistical services.

About Azopharma
Azopharma Product Development Group is FDA registered, DEA approved and client audited on a regular basis. Azopharma’s mission is to help our customers turn Ideas Into Cures™. In product development, it comes down to the right people, their commitment and application of experience. Partnering with Azopharma provides customers with the confidence of assured success. We welcome visits to our South Florida facilities as well as our other sites to conduct audits or meet with our pharmaceutical scientists to outline a study that meets your specific needs. Contact one of our scientists at development@azopdogroup.com or 954-433-7480.

Contact
Phil Meeks, CEO
Azopharma Product Development Group
2 Oakwood Boulevard, Suite 170 Hollywood, FL 33020
Phone: 954-433-7480
www.azopdogroup.com